ARTICLE | Financial News
Singlera raises $60M series A+ round
March 27, 2018 5:07 PM UTC
Singlera Genomics Inc. (La Jolla, Calif.) raised $60 million in a series A+ round led by China-based investors Green Pine Capital Partners and Prosperico Ventures. UCF Medical Investment, Jointown Pharmaceutical Group, Lilly Asia Ventures and other undisclosed investors also participated.
Singlera develops non-invasive genomic tests with a focus on diagnostic tests for early stage cancer. Its technologies include single cell sequencing, DNA methylation and bioinformatics...
BCIQ Company Profiles